Storyline
AstraZeneca plans cell therapy manufacturing and innovation hub in Shanghai
AstraZeneca announced plans to build a commercial cell therapy manufacturing base and an innovation center in Shanghai as part of its $15 billion investment commitment in China.
Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
- Fierce Pharmafiercepharma.com
- Fierce Biotechfiercebiotech.com
- BioPharma Divebiopharmadive.com